openPR Logo
Press release

Generic Drugs Market Projected to Surpass $615 Billion by 2030, Driven by 5.22% Annual Growth

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The ๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ, valued at USD 431.15 billion in 2023, is expected to experience steady growth, reaching nearly USD 615.72 billion by 2030, with a compound annual growth rate (CAGR) of 5.22% from 2024 to 2030.

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Generic drugs are pharmaceutical products that are equivalent to brand-name drugs in dosage, strength, route of administration, quality, and performance, but are sold without the brand name. These drugs are often significantly cheaper than their branded counterparts, making them an attractive option for consumers and healthcare providers. The market for generic drugs is expanding rapidly, driven by the expiration of patents for numerous blockbuster drugs and the increasing demand for affordable healthcare solutions globally. As healthcare costs continue to rise, particularly in developed countries, the adoption of generic drugs is expected to surge, contributing to a positive market outlook. Additionally, the aging global population, which is more susceptible to chronic diseases such as cardiovascular conditions, diabetes, and respiratory disorders, is expected to drive demand for generic medications.

๐†๐ž๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐ฏ๐ž ๐†๐ซ๐š๐ฉ๐ก๐ฌ: https://www.maximizemarketresearch.com/request-sample/25900/

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‚๐จ๐ฏ๐ž๐ซ๐š๐ ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ: ๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

โ€ข ๐๐š๐ฌ๐ž ๐˜๐ž๐š๐ซ: 2023
โ€ข ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐๐ž๐ซ๐ข๐จ๐: 2024-2030
โ€ข ๐‡๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐œ๐š๐ฅ ๐ƒ๐š๐ญ๐š: 2018 to 2023
โ€ข ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐ข๐ง 2023: USD 431.15 billion
โ€ข ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐๐ž๐ซ๐ข๐จ๐ ๐‚๐€๐†๐‘: 5.22%
โ€ข ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐ข๐ง 2030: USD 615.72 billion
โ€ข ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐: Product (Simple Generics, Super Generics, Biosimilars), Application (Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, Others), Distribution Channel (Hospitals, Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, Others)

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

โ€ข ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

1. ๐’๐ข๐ฆ๐ฉ๐ฅ๐ž ๐†๐ž๐ง๐ž๐ซ๐ข๐œ๐ฌ: These are direct copies of branded drugs and are the most common type of generic drugs in the market.
2. ๐’๐ฎ๐ฉ๐ž๐ซ ๐†๐ž๐ง๐ž๐ซ๐ข๐œ๐ฌ: These are modified versions of branded drugs that offer added value, such as improved formulations or delivery mechanisms. This segment held the largest market share of 38% in 2023.
3. ๐๐ข๐จ๐ฌ๐ข๐ฆ๐ข๐ฅ๐š๐ซ๐ฌ: These are generic versions of biologic drugs. They are more complex to produce and validate but offer significant market potential.

โ€ข ๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

1. ๐‚๐š๐ซ๐๐ข๐จ๐ฏ๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ: As major causes of death globally, cardiovascular diseases drive significant demand for generic drugs.
2. ๐€๐ง๐ญ๐ข-๐ˆ๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐ฏ๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ: This segment includes antibiotics and antivirals, essential in combating infectious diseases.
3. ๐€๐ง๐ญ๐ข-๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐ƒ๐ซ๐ฎ๐ ๐ฌ: With the aging population, the demand for affordable arthritis treatments is on the rise.
4. ๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐๐ž๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐ƒ๐ซ๐ฎ๐ ๐ฌ: This segment held the largest market share in 2023, driven by increased awareness of mental health and the availability of cost-effective treatments.
5. ๐€๐ง๐ญ๐ข-๐‚๐š๐ง๐œ๐ž๐ซ ๐ƒ๐ซ๐ฎ๐ ๐ฌ: Generic oncology drugs are critical in making cancer treatment more accessible.
6. ๐‘๐ž๐ฌ๐ฉ๐ข๐ซ๐š๐ญ๐จ๐ซ๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ: With the prevalence of respiratory disorders, this segment continues to grow.
7. ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ: This includes a variety of drugs for different therapeutic areas.

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:

The research methodology employed for analyzing the Generic Drugs Market includes a blend of primary and secondary research. Primary research involved extensive interviews with industry experts, key opinion leaders, and stakeholders. Secondary research included a thorough review of company reports, white papers, government publications, and relevant literature. The combination of these methods ensures a comprehensive and accurate analysis of market dynamics, trends, and forecasts. Data triangulation was employed to validate the findings and enhance the reliability of the projections.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐˜๐จ๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/request-sample/25900/

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐œ๐จ๐ฉ๐ž:

The scope of the Generic Drugs Market report encompasses a detailed analysis of the key market segments, including product types, applications, distribution channels, and regional markets. The report provides insights into market drivers, restraints, opportunities, and challenges, along with the competitive landscape and key strategies adopted by market players. The analysis covers the period from 2018 to 2030, with a focus on the forecast period from 2024 to 2030.

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ž๐›๐ฃ๐ž๐œ๐ญ๐ข๐ฏ๐ž:

The primary objective of the Generic Drugs Market report is to provide a comprehensive analysis of the market trends, growth drivers, and challenges. The report aims to equip stakeholders with actionable insights to make informed decisions, identify growth opportunities, and formulate strategic plans. The report also seeks to analyze the competitive landscape and provide detailed profiles of key players in the market.

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

The Generic Drugs Market is characterized by significant regional variations in market size, growth potential, and key players. North America dominated the market in 2023, holding a 33.21% market share, primarily due to the presence of numerous market players and the widespread adoption of generic drugs in the United States. The prescription pattern in the U.S. is heavily skewed towards branded generics, further fueling market growth. Asia-Pacific is expected to witness the highest CAGR of 6.42% during the forecast period, driven by lower manufacturing costs, a skilled workforce, and a growing focus on making medications more affordable. India, in particular, stands out as a major player in the global market, with the second-highest number of FDA-approved generic drug manufacturing plants outside the United States.

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š ๐จ๐Ÿ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ: https://www.maximizemarketresearch.com/market-report/global-generic-drugs-market/25900/

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

The Generic Drugs Market is highly competitive, with several key players dominating different regions. In North America, companies like Mylan N.V., Pfizer, and Eli Lilly and Company lead the market. In Europe, Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline Plc. are major players, while in Asia-Pacific, Sun Pharma and Lupin Pharmaceuticals hold significant market shares. These companies are actively engaged in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market positions and expand their product portfolios.

๐“๐š๐›๐ฅ๐ž ๐จ๐Ÿ ๐‚๐จ๐ง๐ญ๐ž๐ง๐ญ: ๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics
5. Market Segmentation
o By Product
o By Application
o By Distribution Channel
6. Regional Analysis
7. Competitive Landscape
8. Key Market Players
9. Future Outlook
10. Conclusion
11. Appendix

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ:

1. What are the growth drivers for the Generic Drugs Market?
2. What are the major restraints for market growth?
3. Which region is expected to lead the global market during the forecast period?
4. What is the projected market size and growth rate of the Generic Drugs Market?
5. What segments are covered in the market report?

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

1. Detailed market segmentation and analysis
2. Regional insights and forecasts
3. Competitive landscape and key player profiles
4. Comprehensive market dynamics, including drivers, restraints, opportunities, and challenges
5. Strategic recommendations for market stakeholders

๐Ž๐ฎ๐ซ ๐€๐๐๐ซ๐ž๐ฌ๐ฌ:

๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐๐ฏ๐ญ. ๐‹๐ญ๐.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐ฎ๐ฌ:

Maximize Market Research is rapidly expanding as a leading market research and business consulting firm, servicing clients worldwide. Numerous Fortune 500 organizations have put their trust in our research projects, which are aimed at increasing revenue and growth. We offer a wide range of services in industries such as IT and telecommunications, chemicals, food and beverage, aerospace and defense, healthcare, and many more.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Drugs Market Projected to Surpass $615 Billion by 2030, Driven by 5.22% Annual Growth here

News-ID: 3622843 • Views: โ€ฆ

More Releases from Maximize Market Research Pvt. Ltd.

Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Power Semiconductor Forecast Highlights Energy-Efficiency Surge
Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Po โ€ฆ
According to a new report by Maximize Market Research, the global power semiconductor market was valued at USD 41.63 billion in 2023 and is projected to reach USD 51.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.18% over the forecast period 2024-2030. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28191/ โ™ฆ Key Highlights Market Size & CAGR: USD 41.63 Bn in 2023, expected to reach USD 51.83 Bn byโ€ฆ
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 at 7.7% CAGR - Advanced Drug Delivery Forecast
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 โ€ฆ
According to a new report by Maximize Market Research, the global microneedle drug delivery systems market was valued at roughly US $ 6.11 billion in 2024 and is projected to reach approximately US $ 9.46 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.7%. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/215694/ โ™ฆ Key Highlights Market size & CAGR: Estimated at ~US $ 6.11 billion in 2024, forecast toโ€ฆ
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CAGR - Growth Supported by Sustainability & EV-Driven Demand
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CA โ€ฆ
According to a new report by Maximize Market Research, the global automotive paints market was valued at USD 10.85 billion in 2023 and is projected to reach USD 15.77 billion by 2030, growing at a CAGR of approximately 4.7 % during 2024-2030. The forecast covers global coatings used in vehicle manufacturing and refinish applications, with a focus on key regions such as Asia-Pacific, North America and Europe. โ–บ Get a sampleโ€ฆ
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5% - Global Petrochemicals Forecast Highlights Robust Growth
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5 โ€ฆ
According to a new report by Maximize Market Research, the global petrochemicals market was valued at USD 678.13 billion in 2024 and is projected to reach USD 1,122.31 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The growth is anchored in expanding demand across automotive, electronics, construction, and packaging industries. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/126575/ โ™ฆ Key Highlights Market size + CAGR:โ€ฆ

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโ€ฆ
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De โ€ฆ
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeuticโ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric โ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550โ€ฆ
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โ€ฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™, detailing every single market driver and intricately analyzing the business vertical. This โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drugโ€ฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ€” industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโ€ฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymeraseโ€ฆ